Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion

被引:0
作者
Stephen A Gallo
Jacqueline D Reeves
Himanshu Garg
Brian Foley
Robert W Doms
Robert Blumenthal
机构
[1] Center for Cancer Research Nanobiology Program,Dept. Microbiology
[2] National Cancer Institute at Frederick,undefined
[3] National Institutes of Health,undefined
[4] University of Pennsylvania,undefined
[5] Los Alamos National Laboratories,undefined
来源
Retrovirology | / 3卷
关键词
Human Immunodeficiency Virus; Simian Immunodeficiency Virus; SupT1 Cell; Human Immunodeficiency Virus Envelope; Human Immunodeficiency Virus Gp120;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 218 条
[1]  
Hahn BH(2000)AIDS as a zoonosis: scientific and public health implications Science 287 607-614
[2]  
Shaw GM(2002)Human immunodeficiency virus type 2 J Gen Virol 83 1253-1265
[3]  
De Cock KM(2004)The Stability of the Intact Envelope Glycoproteins is a Major Determinant of Sensitivity of HIV/SIV to Peptidic Fusion Inhibitors J Mol Biol 340 9-14
[4]  
Sharp PM(2003)Membrane fusion Chem Rev 103 53-69
[5]  
Reeves JD(2005)Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV J Med Chem 48 3036-3044
[6]  
Doms RW(2000)Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins FEBS Lett 474 246-251
[7]  
Gallo SA(1998)Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells Biochem Biophys Res Commun 242 219-225
[8]  
Sackett K(2003)The HIV Env-mediated fusion reaction Biochim Biophys Acta 1614 36-50
[9]  
Rawat SS(2002)Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics Proc Natl Acad Sci U S A 99 16249-16254
[10]  
Shai Y(2004)Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity J Virol 78 5476-5485